TrialClinical drug investigation2010

Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study.

Reinhard Ketelhut et al.PubMed ↗Publisher ↗

No numbers read from the abstract.